BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27913098)

  • 1. Succinyl-CoA synthetase (SUCLA2) deficiency in two siblings with impaired activity of other mitochondrial oxidative enzymes in skeletal muscle without mitochondrial DNA depletion.
    Huang X; Bedoyan JK; Demirbas D; Harris DJ; Miron A; Edelheit S; Grahame G; DeBrosse SD; Wong LJ; Hoppel CL; Kerr DS; Anselm I; Berry GT
    Mol Genet Metab; 2017 Mar; 120(3):213-222. PubMed ID: 27913098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness.
    Carrozzo R; Dionisi-Vici C; Steuerwald U; Lucioli S; Deodato F; Di Giandomenico S; Bertini E; Franke B; Kluijtmans LA; Meschini MC; Rizzo C; Piemonte F; Rodenburg R; Santer R; Santorelli FM; van Rooij A; Vermunt-de Koning D; Morava E; Wevers RA
    Brain; 2007 Mar; 130(Pt 3):862-74. PubMed ID: 17301081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion.
    Elpeleg O; Miller C; Hershkovitz E; Bitner-Glindzicz M; Bondi-Rubinstein G; Rahman S; Pagnamenta A; Eshhar S; Saada A
    Am J Hum Genet; 2005 Jun; 76(6):1081-6. PubMed ID: 15877282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mutation in SUCLA2 identified on sequencing analysis.
    Güngör O; Özkaya AK; Güngör G; Karaer K; Dilber C; Aydin K
    Pediatr Int; 2016 Jul; 58(7):659-61. PubMed ID: 26952923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations.
    Ostergaard E; Hansen FJ; Sorensen N; Duno M; Vissing J; Larsen PL; Faeroe O; Thorgrimsson S; Wibrand F; Christensen E; Schwartz M
    Brain; 2007 Mar; 130(Pt 3):853-61. PubMed ID: 17287286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Succinate-CoA ligase deficiency due to mutations in SUCLA2 and SUCLG1: phenotype and genotype correlations in 71 patients.
    Carrozzo R; Verrigni D; Rasmussen M; de Coo R; Amartino H; Bianchi M; Buhas D; Mesli S; Naess K; Born AP; Woldseth B; Prontera P; Batbayli M; Ravn K; Joensen F; Cordelli DM; Santorelli FM; Tulinius M; Darin N; Duno M; Jouvencel P; Burlina A; Stangoni G; Bertini E; Redonnet-Vernhet I; Wibrand F; Dionisi-Vici C; Uusimaa J; Vieira P; Osorio AN; McFarland R; Taylor RW; Holme E; Ostergaard E
    J Inherit Metab Dis; 2016 Mar; 39(2):243-52. PubMed ID: 26475597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screen for abnormal mitochondrial phenotypes in mouse embryonic stem cells identifies a model for succinyl-CoA ligase deficiency and mtDNA depletion.
    Donti TR; Stromberger C; Ge M; Eldin KW; Craigen WJ; Graham BH
    Dis Model Mech; 2014 Feb; 7(2):271-80. PubMed ID: 24271779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial encephalomyopathy and retinoblastoma explained by compound heterozygosity of SUCLA2 point mutation and 13q14 deletion.
    Matilainen S; Isohanni P; Euro L; Lönnqvist T; Pihko H; Kivelä T; Knuutila S; Suomalainen A
    Eur J Hum Genet; 2015 Mar; 23(3):325-30. PubMed ID: 24986829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Succinyl-CoA ligase deficiency: a mitochondrial hepatoencephalomyopathy.
    Van Hove JL; Saenz MS; Thomas JA; Gallagher RC; Lovell MA; Fenton LZ; Shanske S; Myers SM; Wanders RJ; Ruiter J; Turkenburg M; Waterham HR
    Pediatr Res; 2010 Aug; 68(2):159-64. PubMed ID: 20453710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disorders caused by deficiency of succinate-CoA ligase.
    Ostergaard E
    J Inherit Metab Dis; 2008 Apr; 31(2):226-9. PubMed ID: 18392745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal multiorgan failure due to ACAD9 mutation and complex I deficiency with mitochondrial hyperplasia in liver, cardiac myocytes, skeletal muscle, and renal tubules.
    Leslie N; Wang X; Peng Y; Valencia CA; Khuchua Z; Hata J; Witte D; Huang T; Bove KE
    Hum Pathol; 2016 Mar; 49():27-32. PubMed ID: 26826406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lethal neonatal case and review of primary short-chain enoyl-CoA hydratase (SCEH) deficiency associated with secondary lymphocyte pyruvate dehydrogenase complex (PDC) deficiency.
    Bedoyan JK; Yang SP; Ferdinandusse S; Jack RM; Miron A; Grahame G; DeBrosse SD; Hoppel CL; Kerr DS; Wanders RJA
    Mol Genet Metab; 2017 Apr; 120(4):342-349. PubMed ID: 28202214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-occurring Down syndrome and SUCLA2-related mitochondrial depletion syndrome.
    Couser NL; Marchuk DS; Smith LD; Arreola A; Kaiser-Rogers KA; Muenzer J; Pandya A; Gucsavas-Calikoglu M; Powell CM
    Am J Med Genet A; 2017 Oct; 173(10):2720-2724. PubMed ID: 28749033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel SUCLA2 mutation in a Portuguese child associated with "mild" methylmalonic aciduria.
    Nogueira C; Meschini MC; Nesti C; Garcia P; Diogo L; Valongo C; Costa R; Videira A; Vilarinho L; Santorelli FM
    J Child Neurol; 2015 Feb; 30(2):228-32. PubMed ID: 24659738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal infantile lactic acidosis and a novel homozygous mutation in the SUCLG1 gene: a mitochondrial DNA depletion disorder.
    Randolph LM; Jackson HA; Wang J; Shimada H; Sanchez-Lara PA; Wong DA; Wong LJ; Boles RG
    Mol Genet Metab; 2011 Feb; 102(2):149-52. PubMed ID: 21093335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, Molecular, and Computational Analysis in two cases with mitochondrial encephalomyopathy associated with SUCLG1 mutation in a consanguineous family.
    Maalej M; Tej A; Bouguila J; Tilouche S; Majdoub S; Khabou B; Tabbebi M; Felhi R; Ammar M; Mkaouar-Rebai E; Keskes L; Boughamoura L; Fakhfakh F
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1730-1737. PubMed ID: 29217198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the phenotypic spectrum of Succinyl-CoA ligase deficiency through functional validation of a new SUCLG1 variant.
    Donti TR; Masand R; Scott DA; Craigen WJ; Graham BH
    Mol Genet Metab; 2016 Sep; 119(1-2):68-74. PubMed ID: 27484306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Succinyl-CoA Synthetase Dysfunction as a Mechanism of Mitochondrial Encephalomyopathy: More than Just an Oxidative Energy Deficit.
    Lancaster MS; Graham BH
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel SUCLA2 Mutation Presenting as a Complex Childhood Movement Disorder.
    Garone C; Gurgel-Giannetti J; Sanna-Cherchi S; Krishna S; Naini A; Quinzii CM; Hirano M
    J Child Neurol; 2017 Feb; 32(2):246-250. PubMed ID: 27651038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of succinyl-CoA synthetase in mouse forebrain results in hypersuccinylation with perturbed neuronal transcription and metabolism.
    Lancaster MS; Kim B; Doud EH; Tate MD; Sharify AD; Gao H; Chen D; Simpson E; Gillespie P; Chu X; Miller MJ; Wang Y; Liu Y; Mosley AL; Kim J; Graham BH
    Cell Rep; 2023 Oct; 42(10):113241. PubMed ID: 37819759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.